Evidence map›Paper›PMID 34860139›Full record

ArticleRenal failure2021

Utilizing reclassification to explore characteristics and prognosis of KDIGO

Gui-Ying Dong, Jun-Ping Qin, Youzhong An, Yan Kang, Xiangyou Yu, Mingyan Zhao, Xiaochun Ma, Yuhang Ai, Yuan Xu, Xiuming Xi and 14 more

Open access · goldAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Renal failure, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 79% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 20 institutions in 1 country.

Gui-Ying DongMedical Intensive Care Unit, Peking Union Medical College Hospital, Beijing, China.ORCID 0000-0001-7841-2863
Jun-Ping QinDepartment of Critical Care Medicine, Tsinghua changgung Hospital, Beijing, China.
Youzhong AnDepartment of Critical Care Medicine, Peking University People's Hospital, Beijing, China.ORCID 0000-0002-8117-1973
Yan KangDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0002-5715-3900
Xiangyou YuDepartment of Critical Care Medicine, First Affiliated Hospital, Xinjiang Medical University, Urumqi, China.
Mingyan ZhaoDepartment of Critical Care Medicine, The First Affiliated Hospital, Harbin Medical University, Harbin, China.
Xiaochun MaDepartment of Critical Care Medicine, The First Affiliated Hospital of China Medical University, Shenyang, China.
Yuhang AiDepartment of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, China.
Yuan XuDepartment of Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Xiuming XiDepartment of Critical Care Medicine, Fuxing Hospital, Capital Medical University, Beijing, China.
Chuanyun QianDepartment of Emergency Medicine, The First Affiliated Hospital of Kunming Medical College, Kunming, China.
Dawei WuDepartment of Critical Care Medicine, Qilu Hospital, Shandong University, Jinan, China.
Renhua SunDepartment of Critical Care Medicine, Zhejiang Provincial People's Hospital, Hangzhou, China.
Shusheng LiDepartment of Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.
Zhenjie HuDepartment of Critical Care Medicine, Hebei Medical University Fourth Hospital, Shijiazhuang, China.
Xiangyuan CaoDepartment of Critical Care Medicine, Affiliated Hospital of Ningxia Medical University, Yinchuan, China.
Fachun ZhouDepartment of Critical Care Medicine, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Li JiangDepartment of Critical Care Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.
Jiandong LinDepartment of Critical Care Medicine, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Erzhen ChenDepartment of Emergency Medicine, Ruijin Hospital, Shanghai Jiao Tong University, Shanghai, China.
Tiehe QinDepartment of Critical Care Medicine, Guangdong General Hospital, Guangzhou, China.
Zhenyang HeDepartment of Critical Care Medicine, Hainan Provincial People's Hospital, Haikou, China.
Jihong ZhuDepartment of Emergency Medicine, Peking University People's Hospital, Beijing, China.
Bin DuMedical Intensive Care Unit, Peking Union Medical College Hospital, Beijing, China.ORCID 0000-0001-6237-2895
Capital Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNPeking University · CNBeijing Tongren Hospital · CNBeijing Tsinghua Chang Gung Hospital · CNCentral South University · CNChina Medical University · CNFujian Medical University · CNGuangdong General Hospital · CNHarbin Medical University · CNHebei Medical University · CNKunming Medical University · CNNingxia Medical University · CNQilu Hospital of Shandong University · CNShanghai Jiao Tong University · CNSichuan University · CNThe Affiliated Yongchuan Hospital of Chongqing Medical University · CNTongji Hospital · CNXinjiang Medical University · CNZhejiang Provincial People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute kidney injury (AKI) is widespread in the intensive care unit (ICU) and affects patient prognosis. According to Kidney Disease: Improving Global Outcomes (KDIGO) guidelines, the absolute and relative increases of serum creatinine (Scr) are classified into the same stage. Whether the prognosis of the two types of patients is similar in the ICU remains unclear.

methodsAccording to the absolute and relative increase of Scr, AKI stage 1 and stage 3 patients were divided into stage 1a and 1b, stage 3a and 3b groups, respectively. Their demographics, laboratory results, clinical characteristics, and outcomes were analyzed retrospectively.

resultsOf the 345 eligible cases, we analyzed stage 1 because stage 3a group had only one patient. Using 53 or 61.88 µmol/L as the reference Scr (Scr

conclusionICU LOS benefit was more prominent in KDIGO

Indexed as

Intensive Care UnitsAcute Kidney InjuryAgedBiomarkersCreatinineFemaleHumansLength of StayMaleMiddle AgedPractice Guidelines as TopicPrognosisRenal Replacement TherapyRetrospective StudiesRisk FactorsSurvival AnalysisBiomarkersCreatinineAcute kidney injuryintensive care unitKDIGOlength of staymortality

Identifiers

PMID34860139
PMCPMC8648037
OpenAlexW3217618819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.